Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence.
Pulmonary embolism (PE) is a common disorder that is accompanied by significant morbidity and mortality. Although anticoagulation is the standard treatment for PE, thrombolytic therapy, with its ability to produce rapid clot lysis, has long been considered an attractive alternative. Although many studies have been performed over the past three decades, however, the indications for the use of thrombolytic agents in patients with PE remain controversial. In this article, we review the medical literature and provide evidence-based guidelines for the use of thrombolytic therapy. We will also discuss the practical aspects of PE thrombolysis.
Arcasoy
S M
SM
Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, USA. arcasoy@mail.med.upenn.edu
Kreit
J W
JW
D000925:Anticoagulants / Q000627:therapeutic use*; D003657:Decision Making; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy; D016896:Treatment Outcome
D000925:Anticoagulants; D005343:Fibrinolytic Agents